214 related articles for article (PubMed ID: 19945701)
1. The metabolic syndrome predicts incident congestive heart failure: a 20-year follow-up study of elderly Finns.
Wang J; Sarnola K; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
Atherosclerosis; 2010 May; 210(1):237-42. PubMed ID: 19945701
[TBL] [Abstract][Full Text] [Related]
2. The metabolic syndrome predicts incident stroke: a 14-year follow-up study in elderly people in Finland.
Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
Stroke; 2008 Apr; 39(4):1078-83. PubMed ID: 18323501
[TBL] [Abstract][Full Text] [Related]
3. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.
McNeill AM; Katz R; Girman CJ; Rosamond WD; Wagenknecht LE; Barzilay JI; Tracy RP; Savage PJ; Jackson SA
J Am Geriatr Soc; 2006 Sep; 54(9):1317-24. PubMed ID: 16970637
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and incident end-stage peripheral vascular disease: a 14-year follow-up study in elderly Finns.
Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
Diabetes Care; 2007 Dec; 30(12):3099-104. PubMed ID: 17848614
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in the impact of 3-year status changes of metabolic syndrome and its components on incident type 2 diabetes mellitus: a decade of follow-up in the Tehran Lipid and Glucose Study.
Hadaegh F; Abdi A; Kohansal K; Hadaegh P; Azizi F; Tohidi M
Front Endocrinol (Lausanne); 2023; 14():1164771. PubMed ID: 37305040
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome, inflammation, and incident heart failure in the elderly: the cardiovascular health study.
Suzuki T; Katz R; Jenny NS; Zakai NA; LeWinter MM; Barzilay JI; Cushman M
Circ Heart Fail; 2008 Nov; 1(4):242-8. PubMed ID: 19808298
[TBL] [Abstract][Full Text] [Related]
8. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study.
Bahrami H; Bluemke DA; Kronmal R; Bertoni AG; Lloyd-Jones DM; Shahar E; Szklo M; Lima JA
J Am Coll Cardiol; 2008 May; 51(18):1775-83. PubMed ID: 18452784
[TBL] [Abstract][Full Text] [Related]
9. The clinical value of metabolic syndrome and its components with respect to sudden cardiac death using different definitions: Two decades of follow-up from the Tehran Lipid and Glucose Study.
Masrouri S; Moazzeni SS; Cheraghloo N; Azizi F; Hadaegh F
Cardiovasc Diabetol; 2022 Dec; 21(1):269. PubMed ID: 36463175
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome and gallstone disease.
Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
[TBL] [Abstract][Full Text] [Related]
11. Predictors of the incident metabolic syndrome in healthy obese subjects: a decade of follow-up from the Tehran Lipid and Glucose Study.
Hosseinpanah F; Nazeri P; Ghareh S; Tohidi M; Azizi F
Eur J Clin Nutr; 2014 Mar; 68(3):295-9. PubMed ID: 23963276
[TBL] [Abstract][Full Text] [Related]
12. Comparative performance of three metabolic syndrome definitions in the prediction of acute coronary syndrome.
Koutsovasilis A; Protopsaltis J; Triposkiadis F; Kokkoris S; Milionis HJ; Zairis MN; Skoularigis J; Koukoulis G; Korantzopoulos P; Melidonis A; Foussas SG
Intern Med; 2009; 48(4):179-87. PubMed ID: 19218766
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of metabolic syndrome components among the elderly using three different definitions: a cohort study in Finland.
Saukkonen T; Jokelainen J; Timonen M; Cederberg H; Laakso M; Härkönen P; Keinänen-Kiukaanniemi S; Rajala U
Scand J Prim Health Care; 2012 Mar; 30(1):29-34. PubMed ID: 22324547
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 studies.
Osadnik K; Osadnik T; Gierlotka M; Windak A; Tomasik T; Mastej M; Kuras A; Jóźwiak K; Penson PE; Lip GYH; Mikhailidis DP; Toth PP; Catapano AL; Ray KK; Howard G; Tomaszewski M; Charchar FJ; Sattar N; Williams B; MacDonald TM; Banach M; Jóźwiak J
Eur J Prev Cardiol; 2023 Sep; 30(12):1195-1204. PubMed ID: 37039119
[TBL] [Abstract][Full Text] [Related]
15. Performance of two metabolic syndrome definitions in the estimation of cardiovascular disease among hypertensive patients.
Hirota AH; Rodrigues CJ; Borges RL; Ribeiro AB; Zanella MT; Batista MC
J Clin Hypertens (Greenwich); 2010 Aug; 12(8):588-96. PubMed ID: 20695935
[TBL] [Abstract][Full Text] [Related]
16. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus.
Sakurai T; Iimuro S; Araki A; Umegaki H; Ohashi Y; Yokono K; Ito H
Gerontology; 2010; 56(2):141-9. PubMed ID: 19828932
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome and the risk of sudden cardiac death in middle-aged men.
Kurl S; Laaksonen DE; Jae SY; Mäkikallio TH; Zaccardi F; Kauhanen J; Ronkainen K; Laukkanen JA
Int J Cardiol; 2016 Jan; 203():792-7. PubMed ID: 26595786
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome and its components as predictors of stroke in middle-aged and elderly Chinese people.
Jia Z; Wu S; Zhou Y; Wang W; Liu X; Wang L; Wang Y; Wang Y; Liang W; Zhao X; Zhang Y
Neurol Res; 2011 Jun; 33(5):453-9. PubMed ID: 21669112
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study.
Amouzegar A; Mehran L; Hasheminia M; Kheirkhah Rahimabad P; Azizi F
Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155315
[TBL] [Abstract][Full Text] [Related]
20. Impaired fasting glucose: Pro-diabetic, "atheroprotective" and modified by metabolic syndrome.
Onat A; Aydın M; Can G; Cakmak HA; Köroğlu B; Kaya A; Ademoğlu E
World J Diabetes; 2013 Oct; 4(5):210-8. PubMed ID: 24147205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
